This is an advertisement
More than 700 lawsuits allege that Victoza, Byetta, and Januvia increase patients' risk of pancreatic cancer. But manufacturers, plaintiffs allege, failed to warn doctors and patients.
Invokana lawsuits claim that Janssen failed to warn that the diabetes drug could cause diabetic ketoacidosis (DKA) and other serious side effects.
Merck faces lawsuits for its shingles vaccine, Zostavax. Plaintiffs who received the vaccine allege that they suffered serious injuries like shingles, blindness, and even death.
Did Bayer/Johnson & Johnson hype Xarelto benefits while downplaying its bleeding risks? That's what more than 5,000 Xarelto lawsuits claim.
The blood thinner Pradaxa did not have an antidote for its bleeding events until 2015, leading to hundreds of casualties and thousands of lawsuits.
Onglyza and Kombiglyze XR lawsuits allege that drugmaker AstraZeneca for years knew about heart failure risks but failed to adequately warn doctors and patients.
Lawsuits allege that drugmaker Sanofi hid Taxotere's permanent hair loss risks while falsely and illegally promoting the drug to increase profits.
The companies that manufacture and market Abilify failed to warn U.S. patients that the drug could induce compulsive behaviors like gambling.
The diabetes drug Invokana has been linked to diabetic ketoacidosis (DKA), kidney problems, pancreatitis, cardiovascular risks, and bone fractures.
Victoza, a type 2 diabetes drug, may cause pancreatic cancer. Manufacturer Novo Nordisk faces lawsuits for allegedly failing to warn patients and doctors about this risk.
Onglyza and Kombiglyze XR are linked to an increased risk of heart failure. The medications may also cause severe joint pain, pancreatitis, and pancreatic cancer.
Testosterone therapy has been aggressively marketed to men who suffer from "Low T," a vague condition that has little scientific basis.
Xarelto is marketed as being easier to use than the older blood thinner warfarin. But ads fail to mention that Xarelto can cause uncontrolled, irreversible bleeding.
Type 2 diabetes drug Byetta is linked to an increased risk of pancreatic cancer in patients, but the drug's label does not warn about this side effect.
The blood thinner Pradaxa did not have an antidote for its bleeding events until 2015, leading to hundreds of casualties.
Temporary hair loss is common during chemotherapy, but permanent hair loss may be more common with Taxotere than with other types of chemo drugs.
Xarelto has been linked to extreme bleeding events that have spawned thousands of lawsuits. Similar lawsuits have netted millions of dollars in compensation.
The blood thinner Pradaxa is linked to 1,000 deaths from uncontrollable bleeding. Boehringer Ingelheim has already paid $650 million in damages to plaintiffs.
Invokana lawsuits are now awaiting trial in New Jersey. These bellwether trials will help determine if or when Janssen will settle the rest of these cases.
The FDA says Abilify can cause compulsive gambling, shopping, eating, and sex. Abilify patients have filed lawsuits against drug maker Bristol-Myer Squibb.
Johnson & Johnson has yet to settle its Invega lawsuits, but juries have awarded millions in damages for Risperdal, Invega's predecessor.
The antipsychotic drug Risperdal can cause young boys to develop female breast tissue. Many have filed lawsuits against J&J and received large awards.
Thousands filed lawsuits against Pfizer after allegedly developing type 2 diabetes from Lipitor. Most of those cases are still pending.
Opioid lawsuits allege that doctors and drugmakers understated the addictiveness of painkillers. Some have been settled for hundreds of millions of dollars.
Among other side effects, Risperdal can cause boys to develop breast tissue (gynecomastia). Thousands have filed lawsuits against Johnson & Johnson.
Merck's shingles vaccine Zostavax has been administered more than 36 million times. But, lawsuits allege that it may cause complications like eye disorders, paralysis, and even death.
The diabetes drug Invokana may cause serious side effects like diabetic ketoacidosis (DKA), foot and leg amputations, and kidney problems.
The FDA has received thousands of adverse event reports for the popular blood thinner Xarelto, including cases of uncontrollable bleeding in patients, for which it lacks an antidote.